Today: 9 April 2026
Credo Technology (CRDO) stock whipsaws, rebounds after CTO share-sale filing; Needham talk next
7 January 2026
1 min read

Credo Technology (CRDO) stock whipsaws, rebounds after CTO share-sale filing; Needham talk next

New York, Jan 7, 2026, 14:22 EST — Regular session

  • CRDO shares were up 6.7% after dipping about 6% earlier in the session.
  • An SEC filing showed Credo’s CTO sold shares through a family trust under a 10b5-1 plan.
  • Credo said its CEO and CFO will speak at Needham’s Growth Conference on Jan. 14.

Credo Technology Group Holding Ltd shares rebounded on Wednesday, up 6.7% at $141.80 after sliding as much as 6% earlier in the session, as investors digested an insider-sale disclosure. The stock swung between $124.85 and $143.14 in heavy midday trading.

The snapback followed two down sessions to start the week. Credo closed down 2.1% on Monday and fell another 5.2% on Tuesday, with more than 7 million shares trading each day, StockAnalysis.com data showed. StockAnalysis

A Form 4 filed on Tuesday showed Credo chief technology officer and director Chi Fung Cheng sold 30,000 ordinary shares on Jan. 2 through the Cheng Huang Family Trust at weighted-average prices ranging from about $141.48 to $151.04. The filing said the sales were made under a Rule 10b5-1 plan — a pre-set trading program that can allow insiders to sell shares on a schedule — adopted on Sept. 5, 2025, and the trust held about 6.42 million shares after the transactions. d18rn0p25nwr6d.cloudfront.net

Credo, which sells high-speed connectivity chips and active electrical cables used in data-center networks, also flagged its next public checkpoint. The company said on Tuesday that CEO Bill Brennan and CFO Dan Fleming will present at the 28th Annual Needham Growth Conference in New York on Jan. 14 at 9:30 a.m. ET.

The wider tape offered little help in explaining the size of the move. The Nasdaq 100 tracker QQQ was up about 0.4% while the S&P 500 tracker SPY was flat; among AI-linked chip names, Nvidia rose 1.4% and Broadcom gained 1.1%, while Marvell slid 4.3% and Astera Labs added 4.2%. The VanEck Semiconductor ETF was down about 0.6%.

Investors have been leaning on the company’s last outlook as the January quarter runs down. In its Dec. 1 results release, Credo forecast third-quarter revenue of $335 million to $345 million and CEO Brennan called the prior quarter “the strongest quarterly results in Credo’s history.”

But the stock’s reliance on big customers can amplify any wobble in sentiment. Credo’s annual report said one customer accounted for 67% of fiscal 2025 revenue and the top 10 customers made up about 90%, leaving results exposed if large orders shift or slip. SEC

Traders now look to Jan. 14 for any color on demand and whether Credo sticks to its January-quarter targets. Credo’s investor relations site lists the Needham appearance as the next scheduled event. investors.credosemi.com

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Nvidia price forecast: Analysts keep $270–$352 targets as China H200 orders turn into the new risk
Previous Story

Nvidia price forecast: Analysts keep $270–$352 targets as China H200 orders turn into the new risk

XRP price forecast: Ripple token slips as ETF bid cools and U.S. jobs data looms
Next Story

XRP price forecast: Ripple token slips as ETF bid cools and U.S. jobs data looms

Go toTop